Skip to main content

Published locations for Brepocitinib shows potential against mild-to-moderate atopic dermatitis in phase 2 trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Brepocitinib shows potential against mild-to-moderate atopic dermatitis in phase 2 trial

User login

  • Reset your password
  • /content/brepocitinib-shows-potential-against-mild-moderate-atopic-dermatitis-phase-2-trial
  • /dermatology/article/258030/atopic-dermatitis/brepocitinib-shows-potential-against-mild-moderate